Finally, a plan
that listens.

Low-Dose Naltrexone (LDN)

Told your labs look normal but you still don’t feel right? Low-dose naltrexone, titrated to you — one nightly tablet, started low and raised slowly.

Find my match
Recovery Support
LDN Flex-Dose

Low dose.Raised slowly.

How it helps
Low-dose naltrexone studied for its signalling at opioid receptors and glial cells one nightly tablet 0.5 mg 4.5 mg your provider sets each step 0.5 mg 4.5 mg your provider sets each step
A woman in her forties waking rested and unhurried in soft morning light on a seamless olive backdrop For days that ask a lot of youFATIGUE · PAIN · INFLAMMATION
A man in his forties holding a mug of coffee on a seamless olive backdrop, calm and unhurried For pain and inflammationONE NIGHTLY TABLET, TITRATED TO YOU

One Tablet, Titrated To You.

Prescription only Free shipping Provider review in 24h US-licensed pharmacy
3, 6, and 12-month plans at checkout — save up to 20% · Cancel anytime
Your first month is a titration month — 0.5 toward a 4.5 mg nightly maintenance dose — billed monthly while your provider dials it in. Once your dose settles, maintenance plans start from $62/mo.
Compounded medications are not FDA-approved.
RXMen & women

LDN Flex-Dose

Naltrexone Nightly tablet · titration built in For fatigue, pain and inflammation that never got a name — started low, raised slowly. $69/moplans from $62
LDN Flex-DoseNaltrexone Get started Important Safety Information

A smaller dose, doing a different job.

Made for the symptoms that never got a name.

  • Prescribed off-label for persistent fatigue¹
  • Prescribed off-label for ongoing pain¹
  • Studied for its signalling in inflammation¹
  • Non-sedating — not a controlled substance
Start the RECLAIM

¹ Low-dose naltrexone is prescribed off-label; as a compounded medication it is not FDA-approved, and this page describes what it is rather than making any claim to treat or cure any condition. Individual responses vary. Important Safety Information

Built into the tablet

Doses that rise as
your body adjusts.

Most prescriptions start where they end. RECLAIM starts at 0.5 mg and climbs gently across your first month — your provider sets each step, your first month bills monthly while the dose settles, and maintenance begins when your body says so.

  • Provider-set steps, not a fixed template
  • Maintenance at 4.5 mg nightly, plans from $62
Week 1

Start low

0.5 mg nightly — small on purpose, so your body has time to settle.

How you feelUsually no different yet. Starting this low is what keeps it that way.

Weeks 2–4

Step up

Your provider raises the dose only when you’re ready, toward 4.5 mg.

How you feelVivid dreams and lighter sleep are the most commonly reported early effects.

Weeks 4–8

Settle in

The dose holds while your provider reviews how you’re actually doing.

How you feelThose early effects often ease. Anything people notice tends to arrive gradually.

Month 3

Steady state

Maintenance at the dose that suits you, reviewed at every refill.

How you feelSettled into a nightly routine. Individual responses vary.

Board-certified physicianslicensed in your state
Dispensed by a licensed US pharmacylicensed, audited, traceable
Free, discreet shippingincluded in your subscription
What You’ll Take

One capsule each night.

Low-dose naltrexone — the same molecule as the standard 50 mg tablet, compounded to a fraction of that dose at your prescribed strength. Non-sedating, non-habit-forming, not a controlled substance.

Why This Protocol

The titration is the protocol.

Flex dosing from 0.5 to 4.5 mg means your first month is built for adjustment, not commitment — your provider steps the dose only when you're ready.

About this protocol

Technical and clinical context our providers use when evaluating intake for low-dose naltrexone therapy.

The medications

  • LDN Flex-Doselow-dose naltrexone with the titration month built in

Inside the formulas

  • Low-dose naltrexonean opioid-receptor modulator studied for its role in immune and nervous-system signaling

Tablets ship at room temperature. Opioid use is always screened before any prescription. Physician-prescribed and dispensed by a licensed US pharmacy.

Your Titration Arc

Week 1

Start at 0.5 mg nightly. The point of month one is adjustment, not judgment.

Month 1

Titration completes — your provider settles you at the dose that fits, up to 4.5 mg.

Month 2-3

You message your provider about how you actually feel; dose adjustments go through provider review. Individual responses vary.

Ongoing

Maintenance dosing on 3, 6, or 12-month plans from $62/mo — with a provider who keeps listening.

Your timeline to treatment

From personalized intake to ongoing support, we help you get — and stay — on track.

Start The RECLAIM Protocol in 5 simple steps

Answer a few questions about your health, goals, and history — all online, no in-person appointment needed. You'll find out if you're eligible within 24 hours.

Take your online intake on your phone

A US-licensed clinician reviews your intake, follows up on anything that needs clarification, and signs your prescription — typically within 24 hours.

A licensed clinician reviews your intake

Your Rx is filled at a US-licensed 503A pharmacy, sealed, and shipped — room-temperature and ready to go from day one.

US-licensed 503A pharmacy fills your Rx

Your shipment arrives at your door — discreet, room-temperature, and ready to use. One capsule nightly, starting at the low end of your titration. No injections, no needles, no special storage.

Your shipment arrives at your door

Ongoing care from our medical team — message your provider any time, with quick reviews and dose adjustments when needed.

Ongoing care from your provider

Peer-reviewed research and regulatory documents our medical team consults when evaluating intake for this protocol.

FDA / DailyMed

ReVia® (naltrexone hydrochloride) Prescribing Information

Official label for standard-dose (50 mg) naltrexone hydrochloride — pharmacology, contraindications, and safety profile of the molecule. Low-dose naltrexone is compounded and prescribed off-label; this label covers the reference product.
DailyMed

View source

Medical Sciences

Low-Dose Naltrexone (LDN) — Review of Therapeutic Utilization

Peer-reviewed review of how low-dose naltrexone is used in clinical practice, its proposed mechanisms, and the current state of the evidence — which the authors note remains preliminary and based on small studies.
Toljan K, Vrooman B — Medical Sciences 2018

View source

Clinical Rheumatology

The use of low-dose naltrexone (LDN) as a novel anti-inflammatory agent: a review

Review of the pharmacology proposed for naltrexone at low doses, including transient opioid-receptor modulation and glial-cell activity. Describes early-stage human research and calls for larger trials.
Younger J, Parkitny L, McLain D — Clinical Rheumatology 2014

View source

Pharmacotherapy

The Safety and Efficacy of Low-Dose Naltrexone in the Management of Chronic Pain and Inflammation

Peer-reviewed evaluation of low-dose naltrexone's safety profile and the published clinical data, noting that LDN is generally well tolerated and that the evidence base is still developing.
Patten DK, Schultz BG, Berlau DJ — Pharmacotherapy 2018

View source

ReVia® is a registered trademark of its owner. Nuvari is not affiliated with or endorsed by the trademark owner.

Medical notice. The RECLAIM Protocol is physician-prescribed low-dose naltrexone, compounded by a licensed US 503A pharmacy and dispensed only after clinical evaluation. Low-dose naltrexone is prescribed off-label; as a compounded medication it is not FDA-approved, and this page describes what it is rather than making any claim to treat or cure any condition. Naltrexone is contraindicated in patients currently using opioid medications, in acute opioid withdrawal, or with acute hepatitis or liver failure. Common side effects can include vivid dreams, sleep changes, headache, and nausea, often during titration. Naltrexone blocks opioid receptors — inform all healthcare providers and emergency personnel that you are taking this medication. Statements on this site have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual responses vary.
Pairs With

What Reclaim stacks with.

The protocols our providers most often add alongside this one.

Begin the RECLAIM →